[41] reported that the expression of CCR5 in T2DM patients was increased by measuring the peripheral blood mononuclear cells, and CCR5 can be considered an indicator of atherosclerosis in diabetic people by promoting insulin resistance and aggravating pancreatic beta cell dysfunction during the development of diabetes. Here, CCR5 is linked to type 2 diabetes mellitus.